These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
427 related articles for article (PubMed ID: 23488726)
1. Pharmacotherapy for smoking cessation: pharmacological principles and clinical practice. Aubin HJ; Luquiens A; Berlin I Br J Clin Pharmacol; 2014 Feb; 77(2):324-36. PubMed ID: 23488726 [TBL] [Abstract][Full Text] [Related]
2. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cahill K; Stevens S; Perera R; Lancaster T Cochrane Database Syst Rev; 2013 May; 2013(5):CD009329. PubMed ID: 23728690 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of pharmacotherapies to aid smoking cessation in adolescents. Bailey SR; Crew EE; Riske EC; Ammerman S; Robinson TN; Killen JD Paediatr Drugs; 2012 Apr; 14(2):91-108. PubMed ID: 22248234 [TBL] [Abstract][Full Text] [Related]
4. Pharmacotherapy for smoking cessation: present and future. Aubin HJ; Karila L; Reynaud M Curr Pharm Des; 2011; 17(14):1343-50. PubMed ID: 21524268 [TBL] [Abstract][Full Text] [Related]
5. Combination treatment with varenicline and bupropion in an adaptive smoking cessation paradigm. Rose JE; Behm FM Am J Psychiatry; 2014 Nov; 171(11):1199-205. PubMed ID: 24934962 [TBL] [Abstract][Full Text] [Related]
6. Cardiovascular and neuropsychiatric safety of varenicline and bupropion compared with nicotine replacement therapy for smoking cessation: study protocol of a retrospective cohort study using the QResearch general practice database. Kotz D; Simpson C; Viechtbauer W; van Schayck OC; West R; Sheikh A BMJ Open; 2014 Aug; 4(8):e005281. PubMed ID: 25168037 [TBL] [Abstract][Full Text] [Related]
7. [Current and future medical drugs for smoking cessation]. Kusma B; Mache S; Deissenrieder F; Quarcoo D; Welte T; Groneberg D Laryngorhinootologie; 2009 Jun; 88(6):410-9; quiz 420-2. PubMed ID: 19504411 [TBL] [Abstract][Full Text] [Related]
8. Varenicline: a first-line treatment option for smoking cessation. Garrison GD; Dugan SE Clin Ther; 2009 Mar; 31(3):463-91. PubMed ID: 19393839 [TBL] [Abstract][Full Text] [Related]
9. Effects of varenicline and bupropion sustained-release use plus intensive smoking cessation counseling on prolonged abstinence from smoking and on depression, negative affect, and other symptoms of nicotine withdrawal. Cinciripini PM; Robinson JD; Karam-Hage M; Minnix JA; Lam C; Versace F; Brown VL; Engelmann JM; Wetter DW JAMA Psychiatry; 2013 May; 70(5):522-33. PubMed ID: 23536105 [TBL] [Abstract][Full Text] [Related]
10. Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation. Keating GM; Lyseng-Williamson KA Pharmacoeconomics; 2010; 28(3):231-54. PubMed ID: 20108995 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of interventions to combat tobacco addiction: Cochrane update of 2013 reviews. Hartmann-Boyce J; Stead LF; Cahill K; Lancaster T Addiction; 2014 Sep; 109(9):1414-25. PubMed ID: 24995905 [TBL] [Abstract][Full Text] [Related]
12. Antidepressants for smoking cessation. Howes S; Hartmann-Boyce J; Livingstone-Banks J; Hong B; Lindson N Cochrane Database Syst Rev; 2020 Apr; 4(4):CD000031. PubMed ID: 32319681 [TBL] [Abstract][Full Text] [Related]